See also this year's filing and all EDGAR filings for this company.
PDF Report 0001466301_2014_Clovis_Oncology_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.9998058745352189, 'aggregate_val': 52000, 'exp_sum': 267868000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 40576000, 'ResearchAndDevelopmentExpense': 226835000, 'remainder_Expenses': 457000}} |
Graph
Absolute values for 0001466301, Clovis Oncology Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 328,596,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 319,329,000 |
| 2 | PropertyPlantAndEquipmentNet | 955,000 |
| 3 | remainder_Assets | 755,000 |
| 4 | LiabilitiesCurrent | 20,952,000 |
| 5 | LiabilitiesNoncurrent | 88,000 |
| 6 | remainder_Liabilities | 130,709,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 40,576,000 |
| 9 | ResearchAndDevelopmentExpense | 226,835,000 |
| 10 | remainder_Expenses | -267,359,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,146,000 |
| 13 | remainder_ComprehensiveNetIncome | 4,696,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 649,635,000 |
| 1 | Liabilities | 151,749,000 |
| 2 | Expenses | 52,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 497,886,000 |
| 5 | NetIncome | -1,198,000 |
| 6 | ComprehensiveNetIncome | 1,150,000 |
| 7 | BaseVar | 403,639,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.71 |
| 9 | EconomicCapitalRatio | 3.49 |
Edgar->Model Mapping
Feature Distribution
